Cargando…
Clinical Features and Immunophenotypes of Double-Hit Diffuse Large B-Cell Lymphoma
Double-hit (DH) genetics induces a reduction in the complete remission (CR) and, consequently, in poor overall survival (OS) in diffuse large B-cell lymphoma (DLBCL) patients. Unfortunately, DH identification is time-consuming. Here, we retrospectively reviewed 92 newly diagnosed DLBCL patients, str...
Autores principales: | Wu, Cheng-Han, Gau, Jyh-Pyng, Teng, Chieh-Lin Jerry, Shih, Yu-Hsuan, Su, Yu-Chen, Wang, Ren-Ching, Chen, Tsung-Chih |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139504/ https://www.ncbi.nlm.nih.gov/pubmed/35626262 http://dx.doi.org/10.3390/diagnostics12051106 |
Ejemplares similares
-
Clinical Features and Outcomes of Primary Breast Diffuse Large B-Cell Lymphoma: A Matched-Pair Study
por: Teng, Ling-Chiao, et al.
Publicado: (2023) -
Diagnostic Approach for Double-Hit and Triple-Hit Lymphoma Based on Immunophenotypic and Cytogenetic Characteristics of Bone Marrow Specimens
por: Kim, Heyjin, et al.
Publicado: (2020) -
Redefining Remission Induction Chemotherapy Ineligibility by Early Mortality in De Novo Acute Myeloid Leukemia
por: Li, You-Cheng, et al.
Publicado: (2021) -
Decreased CD11c‐positive dendritic cells in the tumor microenvironment predict double‐hit/triple‐hit genotype and survival in diffuse large B‐cell lymphoma
por: Yuan, Chang‐Tsu, et al.
Publicado: (2022) -
Pomalidomide and Dexamethasone Are Effective in Relapsed or Refractory Multiple Myeloma in a Real-Life Setting: A Multicenter Retrospective Study in Taiwan
por: Hung, Yu-Chin, et al.
Publicado: (2021)